SAHIWAL – Deputy Commissioner (DC) Sahiwal, Shahid Mehmood, chaired the first formal meeting of the District Oversight and Coordination Committee to review arrangements for the upcoming National Human Papillomavirus (HPV) vaccination campaign.
The high-level meeting was attended by CEO Health Sahiwal Dr. Abdul Majeed Niazi, District Health Officer (DHO) Dr. Muhammad Tahir Chaudhry, and representatives from various stakeholder departments.
Strategic Goals and Public Safety
Addressing the participants, Deputy Commissioner Shahid Mehmood emphasized that the HPV vaccine is a scientifically proven, safe, and effective shield against cervical cancer, a disease that claims thousands of lives annually. He noted that the campaign aligns with the global recommendations of the World Health Organization (WHO) and the National Ministry of Health.
“Our primary objective is to protect our daughters from this life-threatening disease,” the DC stated. He directed the Health Department to launch a comprehensive district-wide awareness initiative to educate the public on the vaccine’s benefits and to proactively dismantle baseless rumors and misconceptions.
Target Population: 180,000 girls aged 9 to 14 years.
Campaign Duration: September 15 to September 27.
Execution: Vaccination teams will be deployed across the district, operating in schools, health centers, and through mobile outreach units.
Commitment to Success
The committee discussed administrative measures, including security for health teams and community engagement strategies. DC Shahid Mehmood reaffirmed the district administration’s commitment to utilizing all available resources to ensure 100% coverage, urging parents and educators to play their part in this vital public health mission.
Understanding Cervical Cancer
Cervical cancer develops in the cells of the cervix—the lower part of the uterus that connects to the vagina. It is a leading cause of cancer-related deaths among women in developing nations like Pakistan.
The Cause: Most cases are caused by persistent infection with high-risk strains of the Human Papillomavirus (HPV), which is commonly transmitted via skin-to-skin contact.
Prevention: Because early stages often show no symptoms, the disease is frequently termed a “silent killer.” However, it is highly preventable through:
HPV Vaccination: Ideally administered before exposure to the virus.
Regular Screening: Such as Pap smears or HPV DNA testing.
Awareness: Understanding the risks and seeking early medical consultation.